Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium lactis MAK16B42L and Increased PMN Cell Phagocytic Capacity

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Bifidobacterium lactis HN019 on increasing PMN cell phagocytic capacity, with effect sizes ranging from moderate to large. 3 of 4 findings reached statistical significance. The most-studied population was healthy elderly adults, and the evidence suggests consistent immune-enhancing effects.

  • Studied populations: healthy elderly adults, healthy adults

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary.

Generated May 12, 2026
4 of 4 papers
Back to top